Net Haskins, M.S. is a Scientist II at Amgen, specializing in antibody discovery and optimization. She holds master’s degrees in Biological Sciences from the University of Maryland and Biochemistry and Molecular Biology from Georgetown University. Her current role involves co-leading biologics projects, focusing on antibody production, purification, developability assays, and high-throughput workflows. Previously, at AstraZeneca, she led projects on antibody engineering, COVID-19 therapeutics, and T-cell engager platforms, contributing to multiple pipeline advancements, publications, and invention disclosures. Her extensive experience at Children's National Medical Center included research on rare metabolic diseases, protein interactions, and assay development. Net’s expertise spans molecular cloning, protein engineering, and high-throughput assay design, with a strong track record of innovation, collaboration, and scientific communication.